Chemoinformaics analysis of Dihydromikanolide
Molecular Weight | 292.287 | nRot | 0 |
Heavy Atom Molecular Weight | 276.159 | nRig | 22 |
Exact Molecular Weight | 292.095 | nRing | 5 |
Solubility: LogS | -2.658 | nHRing | 4 |
Solubility: LogP | 1.189 | No. of Aliphatic Rings | 5 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 37 | No. of Aliphatic Hetero Cycles | 4 |
No. of Heavy Atom | 21 | No. of Aromatic Carbocycles | 0 |
nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 3 |
No. of Carbon atom | 15 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 6 | No. of Arom Bond | 0 |
nHA | 6 | APOL | 40.5307 |
nHD | 0 | BPOL | 24.7313 |
QED | 0.578 |
Synth | 6.263 |
Natural Product Likeliness | 2.667 |
NR-PPAR-gamma | 0.843 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.003 |
HIA | 0.008 |
CACO-2 | -5.127 |
MDCK | 0.0000164 |
BBB | 0.559 |
PPB | 0.73477 |
VDSS | 1.489 |
FU | 0.374017 |
CYP1A2-inh | 0.022 |
CYP1A2-sub | 0.65 |
CYP2c19-inh | 0.026 |
CYP2c19-sub | 0.842 |
CYP2c9-inh | 0.014 |
CYP2c9-sub | 0.082 |
CYP2d6-inh | 0.013 |
CYP2d6-sub | 0.259 |
CYP3a4-inh | 0.047 |
CYP3a4-sub | 0.438 |
CL | 14.733 |
T12 | 0.139 |
hERG | 0.005 |
Ames | 0.028 |
ROA | 0.957 |
SkinSen | 0.069 |
Carcinogencity | 0.577 |
EI | 0.017 |
Respiratory | 0.311 |
NR-Aromatase | 0.768 |
Antiviral | Yes |
Prediction | 0.872581 |